From April 1, 2022 to June 30, 2022, the company has repurchased 465,000 shares, representing 0.34% for CNY 54.99 million. With this, the company has completed the repurchase of 825,000 shares, representing 0.61% for CNY 115.98 million under the buyback announced on October 29, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62.82 CNY | -0.29% | +8.31% | -18.98% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.98% | 1.15B | |
-4.24% | 86.85B | |
+2.76% | 40.16B | |
-16.98% | 31.28B | |
+57.86% | 25.27B | |
-16.24% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-17.10% | 11.69B | |
+6.89% | 8.83B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Tranche Update on Chengdu Kanghua Biological Products Co., Ltd.'s Equity Buyback Plan announced on October 29, 2021.